Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Jan;57(1):261-8.
doi: 10.1128/AAC.01454-12. Epub 2012 Oct 31.

Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy

Affiliations
Comparative Study

Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy

Truc T Tran et al. Antimicrob Agents Chemother. 2013 Jan.

Abstract

Development of daptomycin (DAP) resistance in Enterococcus faecalis has recently been associated with mutations in genes encoding proteins with two main functions: (i) control of the cell envelope stress response to antibiotics and antimicrobial peptides (LiaFSR system) and (ii) cell membrane phospholipid metabolism (glycerophosphoryl diester phosphodiesterase and cardiolipin synthase [cls]). However, the genetic bases for DAP resistance in Enterococcus faecium are unclear. We performed whole-genome comparative analysis of a clinical strain pair, DAP-susceptible E. faecium S447 and its DAP-resistant derivative R446, which was recovered from a single patient during DAP therapy. By comparative whole-genome sequencing, DAP resistance in R446 was associated with changes in 8 genes. Two of these genes encoded proteins involved in phospholipid metabolism: (i) an R218Q substitution in Cls and (ii) an A292G reversion in a putative cyclopropane fatty acid synthase enzyme. The DAP-resistant derivative R446 also exhibited an S333L substitution in the putative histidine kinase YycG, a member of the YycFG system, which, similar to LiaFSR, has been involved in cell envelope homeostasis and DAP resistance in other Gram-positive cocci. Additional changes identified in E. faecium R446 (DAP resistant) included two putative proteins involved in transport (one for carbohydrate and one for sulfate) and three enzymes predicted to play a role in general metabolism. Exchange of the "susceptible" cls allele from S447 for the "resistant" one belonging to R446 did not affect DAP susceptibility. Our results suggest that, apart from the LiaFSR system, the essential YycFG system is likely to be an important mediator of DAP resistance in some E. faecium strains.

PubMed Disclaimer

Figures

Fig 1
Fig 1
The Yyc system in E. faecium. (A) Structural organization of the orthologous yyc gene cluster in E. faecium; transmembrane coding regions are marked as black bars. Annotations are based on a published report by Türck et al. (49). (B) Predicted domain architecture of the putative YycG histidine kinase and changes found in E. faecium R446, TX0133a, and TX0133a.4, with black arrows denoting the localization of the predicted amino acid changes. Numbers indicate the corresponding amino acids spanning each domain. The HAMP domain is predicted to promote communication between the input and output domains; the PAS sensor domain was named for homology to the PER-ARNT-SIM proteins of D. melanogaster; HisKA, phosphoacceptor domain of histidine kinases; HATPase_c, histidine kinase-like ATPase. The scheme was based in part on published data from Dubrac et al. (56).

Similar articles

Cited by

References

    1. Arias CA, Contreras GA, Murray BE. 2010. Management of multidrug-resistant enterococcal infections. Clin. Microbiol. Infect. 16:555–562 - PMC - PubMed
    1. Cantón R, Ruiz-Garbajosa P, Chaves RL, Johnson AP. 2010. A potential role for daptomycin in enterococcal infections: what is the evidence? J. Antimicrob. Chemother. 65:1126–1136 - PMC - PubMed
    1. Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J. 2010. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study. Clin. Ther. 32:1713–1719 - PubMed
    1. Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE. 2012. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. J. Hosp. Med. 7:243–248 - PubMed
    1. Fraher MH, Corcoran GD, Creagh S, Feeney E. 2007. Daptomycin-resistant Enterococcus faecium in a patient with no prior exposure to daptomycin. J. Hosp. Infect. 65:376–378 - PubMed

Publication types

MeSH terms